ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 2588

$707K Total Retail Price of All Prescriptions

Rank: 227 out of 2588

449 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

16% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 14,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 752 633 1 1
LEVOTHYROXINE SODIUM 710 639 2 2
FUROSEMIDE 684 593 3 5
LISINOPRIL 580 468 4 3
OMEPRAZOLE 481 393 5 6
SPIRONOLACTONE 467 436 6 58
METFORMIN HCL 435 373 7 8
WARFARIN SODIUM 432 394 8 10
METOPROLOL TARTRATE 426 369 9 9
POTASSIUM CHLORIDE 393 377 10 15
GLIPIZIDE 324 264 11 44
HYDROCODONE-ACETAMINOPHEN 297 247 S3 12 7
ATENOLOL 239 211 13 14
HYDROCHLOROTHIAZIDE 232 212 14 13
METOPROLOL SUCCINATE 215 203 15 12
DOXAZOSIN MESYLATE 204 195 16 96
ALLOPURINOL 203 193 17 33
AMLODIPINE BESYLATE 187 172 18 4
ATORVASTATIN CALCIUM 181 158 19 11
RISPERIDONE 155 123 20 57
CARVEDILOL 155 138 20 20
GEMFIBROZIL 144 116 22 123
CLOPIDOGREL 140 112 23 30
TAMSULOSIN HCL 140 103 23 23
PANTOPRAZOLE SODIUM 134 134 25 28
CARBIDOPA-LEVODOPA 127 116 26 83
DIGOXIN 126 121 27 38
ENALAPRIL MALEATE 126 95 27 31
PREDNISONE 123 112 29 42
TRAMADOL HCL 122 103 30 19
LANTUS 122 77 30 47
PRAVASTATIN SODIUM 120 104 32 16
MECLIZINE HCL 116 105 33 120
LOSARTAN POTASSIUM 115 97 34 17
PROAIR HFA 113 97 35 50
GABAPENTIN 112 88 36 18
OXYBUTYNIN CHLORIDE ER 110 79 37 85
CAPTOPRIL 106 94 38 333
SERTRALINE HCL 105 97 39 26
MIRTAZAPINE 103 92 40 63
DILTIAZEM ER 100 100 41 150
POLYETHYLENE GLYCOL 3350 99 96 42 55
DIOVAN 99 91 42 29
NYSTATIN-TRIAMCINOLONE 96 60 44 158
CIPROFLOXACIN HCL 96 91 44 82
PLAVIX 94 79 46 43
DIOVAN HCT 93 80 47 72
AZITHROMYCIN 91 80 48 45
TRIAMCINOLONE ACETONIDE 89 59 49 106
TRIAMTERENE-HCTZ 89 77 49 46
FENTANYL 84 84 S2 51 78
OXYBUTYNIN CHLORIDE 83 60 52 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 74 53 35
DONEPEZIL HCL 80 78 53 22
AMOXICILLIN 78 65 55 130
DILTIAZEM 24HR CD 75 75 56 98
PAROXETINE HCL 75 48 56 71
PHENYTOIN SODIUM EXTENDED 74 47 58 109
LOVASTATIN 72 72 59 34
ADVAIR DISKUS 70 36 60 48
NABUMETONE 68 56 61 147
CITALOPRAM HBR 68 67 61 27
RAMIPRIL 65 65 63 111
INSULIN SYRINGE 65 49 63 81
VERAPAMIL ER 62 62 65 102
QUETIAPINE FUMARATE 62 50 65 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 45 67 127
CEFUROXIME 60 56 68 183
GLYBURIDE 60 60 R 68 65
SUCRALFATE 59 55 70 193
NITROGLYCERIN PATCH 59 47 70 149
RANITIDINE HCL 54 51 72 37
PROPRANOLOL HCL 54 42 72 128
NAMENDA 53 52 74 32
PRAMIPEXOLE DIHYDROCHLORIDE 53 29 74 188
ACETAMINOPHEN-CODEINE 53 41 S3 74 80
NIFEDIPINE ER 53 53 74 59
ESCITALOPRAM OXALATE 50 41 78 68
KLOR-CON M20 50 33 78 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.